Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis

Whether Nucleos(t)ide analogs(NA) treatment can delay the onset of HCC remains unclear. We retrospectively analyzed the clinical data of patients with HBV-related cirrhosis and HCC from 2000 to 2012. Cox proportional hazards model was used to explore the association between NA treatment and postpone...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Jingfeng, Zhang, Zheng, Qin, Enqiang, Hou, Jun, Liu, Shuiwen, Liu, Zengmin, Li, Shuo, Wei, Zhenman, Zhong, Yanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722517/
https://www.ncbi.nlm.nih.gov/pubmed/29228565
http://dx.doi.org/10.18632/oncotarget.18075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722517/
https://www.ncbi.nlm.nih.gov/pubmed/29228565
http://dx.doi.org/10.18632/oncotarget.18075

Ejemplares similares